2005.HK लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 13:38):

Stats
आज की मात्रा	2.42M
औसत मात्रा	2.05M
बाजार मूल्य	14.16B
EPS	HKD0 ( 2024-03-27 )
Last Dividend	HKD0.0700 ( 2023-09-14 )
Next Dividend	HKD0 ( N/A )
P/E	10.84
ATR14	HKD0.00700 (0.15%)

मात्रा सहसंबंध

लंबा: -0.12 (neutral)

छोटा: -0.43 (neutral)

Signal:(48.323) Neutral

SSY Group Ltd सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

SSY Group Ltd सहसंबंध - मुद्रा/वस्त्र

0.11
( neutral )

-0.19
( neutral )

0.00
( neutral )

0.66
( moderate )

-0.22
( neutral )

SSY Group Ltd वित्तीय

Annual	2023
राजस्व:	HKD6.46B
सकल लाभ:	HKD3.49B (53.99 %)
EPS:	HKD0.440

FY	2023
राजस्व:	HKD6.46B
सकल लाभ:	HKD3.49B (53.99 %)
EPS:	HKD0.440

FY	2022
राजस्व:	HKD6.43B
सकल लाभ:	HKD3.44B (53.46 %)
EPS:	HKD0.380

FY	2021
राजस्व:	HKD5.36B
सकल लाभ:	HKD3.17B (59.18 %)
EPS:	HKD0.260

Financial Reports:

No articles found.

SSY Group Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.0600 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.160 (N/A)	HKD0.0700 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

SSY Group Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.77 - Increase likely (55.42%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.00500	2008-05-23
Last Dividend	HKD0.0700	2023-09-14
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	HKD1.257	--
Avg. Dividend % Per Year	0.00%	--
Score	4.32	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.77
Div. Directional Score	10.00	--

Next Divdend (Est)
(2024-07-09)

HKD0.0719 Estimate 12.38 %

Dividend Stability

0.50 Below Average

Dividend Score

4.32

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
9616.HK	Ex Dividend Junior	2023-08-07	Annually	0.00%
2119.HK	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
1120.HK	Ex Dividend Knight	2023-06-12	Annually	0.00%
0207.HK	Ex Dividend Junior	2023-06-12	Sporadic	0.00%
3818.HK	Ex Dividend Knight	2023-08-21	Annually	0.00%
1709.HK	No Dividend Player	2023-09-13	Annually	0.00%
0737.HK	Ex Dividend Knight	2023-09-21	Semi-Annually	0.00%
2289.HK	Ex Dividend Junior	2023-06-29	Annually	0.00%
1277.HK	Ex Dividend Knight	2023-10-09	Semi-Annually	0.00%
0335.HK	Ex Dividend Knight	2023-09-04	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.204	1.500	5.92	8.88	[0 - 0.5]
returnOnAssetsTTM	0.110	1.200	6.33	7.59	[0 - 0.3]
returnOnEquityTTM	0.199	1.500	8.91	10.00	[0.1 - 1]
payoutRatioTTM	0.338	-1.000	6.62	-6.62	[0 - 1]
currentRatioTTM	2.03	0.800	4.84	3.87	[1 - 3]
quickRatioTTM	1.587	0.800	5.37	4.30	[0.8 - 2.5]
cashRatioTTM	0.659	1.500	7.45	10.00	[0.2 - 2]
debtRatioTTM	0.282	-1.500	5.31	-7.96	[0 - 0.6]
interestCoverageTTM	11.88	1.000	6.71	6.71	[3 - 30]
operatingCashFlowPerShareTTM	0.325	2.00	9.89	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0880	2.00	9.96	10.00	[0 - 20]
debtEquityRatioTTM	0.486	-1.500	8.06	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.540	1.000	4.34	4.34	[0.2 - 0.8]
operatingProfitMarginTTM	0.231	1.000	7.39	7.39	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.287	1.000	9.52	9.52	[0.2 - 2]
assetTurnoverTTM	0.540	0.800	9.73	7.79	[0.5 - 2]
Total Score				12.25

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.78	1.000	9.01	0	[1 - 100]
returnOnEquityTTM	0.199	2.50	9.30	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0880	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	4.81	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.325	2.00	9.89	10.00	[0 - 30]
payoutRatioTTM	0.338	1.500	6.62	-6.62	[0 - 1]
pegRatioTTM	0.559	1.500	9.61	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.149	1.000	8.76	0	[0.1 - 0.5]
Total Score				7.77

SSY Group Ltd

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.